Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease - PubMed (original) (raw)
Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease
D P Sandler et al. Ann Intern Med. 1991.
Abstract
Objective: To evaluate the risk for chronic renal disease associated with regular use of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs).
Design: Multicenter case-control study.
Patients: Patients were 554 North Carolina residents (age range, 30 to 79 years) hospitalized between 1980 and 1982 with a discharge diagnosis indicating newly diagnosed chronic renal dysfunction and a serum creatinine level consistently at or above 130 mumol/L (1.5 mg/dL). Controls were 516 persons chosen randomly by telephone screening (if younger than 65 years of age) and from listings of Medicare recipients (if 65 years of age or older), frequency-matched to patients by age, race, sex, and proximity to study hospitals.
Measurements: Data on use of prescription NSAIDs and other analgesics before 1980, other risk factors, and potential confounders were obtained by telephone interviews. Patients were classified by frequency and duration of use; daily users were those who took an NSAID for at least 360 consecutive days.
Main results: A twofold risk for chronic renal disease was associated with previous daily use of NSAIDs (adjusted odds ratio, 2.1; 95% Cl, 1.1 to 4.1). Increased risk was predominantly limited to men older than 65 years, for whom the odds ratio for daily use was 10.0 (Cl, 1.2 to 82.7) after adjusting for use of other analgesics. In other age-sex groups, the risk associated with NSAID use tended to be increased among those with heart disease or other factors that might indicate compromised renal circulation. These findings did not result from confounding by known renal disease risk factors and were not readily explained by potential biases.
Conclusions: Regular use of NSAIDs may increase the risk for chronic kidney disease in some high-risk groups. With the recent over-the-counter availability and increasing popularity of NSAIDs, the possibility of an increased risk for chronic renal disease associated with their use may warrant further scrutiny.
Comment in
- Nonsteroidal anti-inflammatory drugs and renal disease--still unsettled.
Wagner EH. Wagner EH. Ann Intern Med. 1991 Aug 1;115(3):227-8. doi: 10.7326/0003-4819-115-3-227. Ann Intern Med. 1991. PMID: 2058878 No abstract available.
Similar articles
- Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study.
Johnsen SP, Pedersen L, Friis S, Blot WJ, McLaughlin JK, Olsen JH, Sørensen HT. Johnsen SP, et al. Stroke. 2003 Feb;34(2):387-91. doi: 10.1161/01.str.0000054057.11892.5b. Stroke. 2003. PMID: 12574547 - Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study.
Henry D, Page J, Whyte I, Nanra R, Hall C. Henry D, et al. Br J Clin Pharmacol. 1997 Jul;44(1):85-90. doi: 10.1046/j.1365-2125.1997.00631.x. Br J Clin Pharmacol. 1997. PMID: 9241101 Free PMC article. - Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT. Johnsen SP, et al. Arch Intern Med. 2005 May 9;165(9):978-84. doi: 10.1001/archinte.165.9.978. Arch Intern Med. 2005. PMID: 15883235 - Analgesic abuse in the elderly. Renal sequelae and management.
Elseviers MM, De Broe ME. Elseviers MM, et al. Drugs Aging. 1998 May;12(5):391-400. doi: 10.2165/00002512-199812050-00005. Drugs Aging. 1998. PMID: 9606616 Review. - NSAIDs and blood pressure. Clinical importance for older patients.
Johnson AG. Johnson AG. Drugs Aging. 1998 Jan;12(1):17-27. doi: 10.2165/00002512-199812010-00003. Drugs Aging. 1998. PMID: 9467684 Review.
Cited by
- Dipstick Leukocyturia as a Kidney Damage Biomarker in Rural Uganda and Kenya.
Mohamed S, Hsu CY, Charlebois ED, Kabami J, Atukunda M, Ayieko J, Orori G, Hickey MD, Petersen M, Kamya MR, Havlir D, Estrella MM, Muiru AN. Mohamed S, et al. Kidney Med. 2024 Aug 14;6(10):100895. doi: 10.1016/j.xkme.2024.100895. eCollection 2024 Oct. Kidney Med. 2024. PMID: 39296806 Free PMC article. No abstract available. - Novel perspectives on leptin in osteoarthritis: Focus on aging.
Liu Z, Xie W, Li H, Liu X, Lu Y, Lu B, Deng Z, Li Y. Liu Z, et al. Genes Dis. 2023 Nov 4;11(6):101159. doi: 10.1016/j.gendis.2023.101159. eCollection 2024 Nov. Genes Dis. 2023. PMID: 39229323 Free PMC article. Review. - Prevalence of Chronic Kidney Disease in a High-Risk Population in Urban Lahore, Pakistan: A Cross-sectional Study.
Khan A, Cheema MF, Fatima R, Cheema SS, Butt Z, Gillani S, Ahmad A, Subhan Ullah M, Jalal U, Cheema S. Khan A, et al. Cureus. 2024 Jun 27;16(6):e63296. doi: 10.7759/cureus.63296. eCollection 2024 Jun. Cureus. 2024. PMID: 39077231 Free PMC article. - Drug stewardship in chronic kidney disease to achieve effective and safe medication use.
Hall RK, Kazancıoğlu R, Thanachayanont T, Wong G, Sabanayagam D, Battistella M, Ahmed SB, Inker LA, Barreto EF, Fu EL, Clase CM, Carrero JJ. Hall RK, et al. Nat Rev Nephrol. 2024 Jun;20(6):386-401. doi: 10.1038/s41581-024-00823-3. Epub 2024 Mar 15. Nat Rev Nephrol. 2024. PMID: 38491222 Review. - Acute Kidney Injury in a Cohort of Critical Illness Patients Exposed to Non-Steroidal Anti-Inflammatory Drugs.
Oliveros H, Buitrago G. Oliveros H, et al. Pharmaceuticals (Basel). 2022 Nov 14;15(11):1409. doi: 10.3390/ph15111409. Pharmaceuticals (Basel). 2022. PMID: 36422539 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical